Cresset Asset Management’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.8K | Hold |
35,984
| – | – | ﹤0.01% | 1588 |
|
|
2025
Q1 | $48.9K | Hold |
35,984
| – | – | ﹤0.01% | 1618 |
|
|
2024
Q4 | $47.9K | Sell |
35,984
-340
| -0.9% | -$452 | ﹤0.01% | 1619 |
|
|
2024
Q3 | $42.1K | Hold |
36,324
| – | – | ﹤0.01% | 2038 |
|
|
2024
Q2 | $48.3K | Buy |
36,324
+24,793
| +215% | +$33K | ﹤0.01% | 1952 |
|
|
2024
Q1 | $22.7K | Sell |
11,531
-300,082
| -96% | -$591K | ﹤0.01% | 1856 |
|
|
2023
Q4 | $439K | Hold |
311,613
| – | – | ﹤0.01% | 1267 |
|
|
2023
Q3 | $402K | Sell |
311,613
-2,592
| -0.8% | -$3.34K | ﹤0.01% | 1251 |
|
|
2023
Q2 | $540K | Buy |
314,205
+294,196
| +1,470% | +$506K | ﹤0.01% | 1105 |
|
|
2023
Q1 | $36.2K | Buy |
20,009
+4,094
| +26% | +$7.41K | ﹤0.01% | 794 |
|
|
2022
Q4 | $34.2K | Hold |
15,915
| – | – | ﹤0.01% | 691 |
|
|
2022
Q3 | $53K | Hold |
15,915
| – | – | ﹤0.01% | 857 |
|
|
2022
Q2 | $58K | Buy |
15,915
+3,050
| +24% | +$11.1K | ﹤0.01% | 899 |
|
|
2022
Q1 | $65K | Hold |
12,865
| – | – | ﹤0.01% | 966 |
|
|
2021
Q4 | $98K | Buy |
+12,865
| New | +$98K | ﹤0.01% | 1089 |
|